Latest News

Award of the Maresch-Klingelhöffer Prize

Prof. Jindrich Cinatl, Dr. Constanze Schneider, Dr. Jürgen Vogt As part of the ceremony to mark the 25th anniversary of the Frankfurt Foundation for Children with Cancer in November 2019, Dr. Constanze Schneider was awarded the Maresch-Klingelhöffer Prize. The prize has been a…

New insights into ALL therapy

Mystery of anticancer drug nelarabine for leukaemia treatment solved Acute lymphoblastic leukaemia (ALL) is the most common cancer in children. With the active substance nelarabine, T-ALL, a subtype that resembles T-lymphocytes, can be treated well. However, B-ALL, a subtype t…

Interview with Prof. Dr. Jindrich Cinatl

Read here the detailed interview published in the magazine “Wissen wird” of the University Hospital Frankfurt, issue 2/2020, in December 2020.

Research helps – Not only now

Childhood cancer hits everyone involved like a “bolt from the blue”. From one moment to the next, the view of the world changes, the focus of life shifts. The affected child, the parents, even the entire environment usually fall into a “deep hole”. Despair and struggling with …

Visualizing Molecular Patterns of Membrane TNF Receptors using single-molecule microscopy

The question of whether a sick cell dies, divides, or travels through the body is regulated by signal molecules that bind and activate receptors on the cell membrane. Among the most important molecular cues in the immune system is Tumor Necrosis Factor α (TNFα) that binds to T…

25 years plus 1 – A review

In September 1994, the Frankfurt Foundation for Children with Cancer was established with the aim of developing new therapy concepts and treatment options for children with cancer. In November 2019, under the patronage of Hesse’s Prime Minister Volker Bouffier, it celebrated i…

Blood cancer: When drugs work

New marker found for the treatment of leukaemia patients Patients suffering from acute myeloid leukaemia (AML) – a certain form of blood cancer – are treated with the help of chemotherapy. Often, the active substances Decitabine and Azacitidine – so-called DNA methyltransferas…

Financial resources for research

Dr. Sjoerd van Wijk, group leader at the Institute of Experimental Cancer Research in Pediatrics, received a research grant from the German Research Foundation (DFG) to further expand his own research group working on the regulation of ubiquitination in cell fate control. Prev…


Frankfurt Foundation
for children with cancer
Komturstraße 3a
60528 Frankfurt

Phone +49 (0)69 678665-0
Fax +49 (0)69 678665-94

Donation account

Frankfurter Sparkasse 1822
IBAN: DE43 5005 0201 1245 6354 40

Charity shopping

Make a good deed out of every online purchase and support the Frankfurt Foundation for Children with Cancer. It's easy to do so via Gooding or AmazonSmile.


Here's how Gooding works: